Rapid Rx Quiz: Diabetes Drugs

Mary L. Windle, PharmD

Disclosures

May 13, 2022

Dipeptidyl peptidase 4 (DPP-4) inhibitors such as sitagliptin are intended for use as monotherapy or in combination with metformin or a thiazolidinedione in patients with T2D as an adjunct to diet and exercise. Sitagliptin should not be used in patients with type 1 diabetes. It has not been studied in patients with a history of pancreatitis who may be at increased risk while using sitagliptin. Heart failure has been observed with other DPP-4 inhibitors.

Learn more about sitagliptin.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....